Alpha Tau Medical (DRTS) Change in Account Payables (2021 - 2022)

Alpha Tau Medical's (DRTS) quarterly Change in Account Payables came in at -$2.6 million in Q2 2022, down 200.23% quarter-over-quarter from $2.6 million in Q1 2022.

Alpha Tau Medical (DRTS) Change in Account Payables (2021 - 2022) Analysis & Trends

Alpha Tau Medical has disclosed Change in Account Payables across 2 years of filings, most recently posting -$2.6 million for Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -3.26 Mn
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 35.60 Mn
9 Abivax 94.37 Bn 94.37 Bn - -9.42 Mn
10 Alpha Tau Medical 2,416.70 -76.42 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2022 -2.63 Mn
Jun 30, 2022 -2.63 Mn
Mar 31, 2022 2.63 Mn
Mar 31, 2022 2.63 Mn
Mar 31, 2021 72,000.00
Mar 31, 2021 72,000.00